Vaccine after cone surgery for cervical dysplasia
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether giving an HPV vaccine after a cone biopsy (a surgery to remove abnormal cells from the cervix) helps prevent the HPV-related disease from coming back. It may be an option for patients who have had treatment for cervical dysplasia and have not been vaccinated against HPV before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had treatment for a condition caused by HPV
- You have not received any HPV vaccine in the past
- You are willing to receive an HPV vaccine as part of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether getting the HPV vaccine after a LEEP (a procedure to remove abnormal cervical cells) can help prevent the abnormal cells from coming back. It's for women who have had high-grade cervical changes or very early cervical cancer.
This study tests whether removing a small piece of the cervix (cone biopsy) can help diagnose hidden precancer when regular tests are unclear. It may help you get a clearer diagnosis if you have ongoing HPV or abnormal cell changes.
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
This study looks at women with early-stage cervical cancer (stage IB2) or a pre-cancer called AIS. The goal is to see if testing for HPV after a cone biopsy can help predict if the cancer will come back. Your HPV test results will be tracked over time.
This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.